Skorpios Trust’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37M | Sell |
3,256,181
-3,650,000
| -53% | -$41.4M | 99.62% | 1 |
|
|
2025
Q1 | $45.9M | Hold |
6,906,181
| – | – | 99.7% | 1 |
|
|
2024
Q4 | $76.2M | Sell |
6,906,181
-2,000,000
| -22% | -$22.1M | 99.8% | 1 |
|
|
2024
Q3 | $109M | Sell |
8,906,181
-1,937,500
| -18% | -$23.8M | 99.85% | 1 |
|
|
2024
Q2 | $146M | Sell |
10,843,681
-3,600,000
| -25% | -$48.6M | 99.89% | 1 |
|
|
2024
Q1 | $195M | Hold |
14,443,681
| – | – | 99.92% | 1 |
|
|
2023
Q4 | $76M | Hold |
14,443,681
| – | – | 99.8% | 1 |
|
|
2023
Q3 | $56.9M | Hold |
14,443,681
| – | – | 99.78% | 1 |
|
|
2023
Q2 | $154M | Hold |
14,443,681
| – | – | 66.67% | 1 |
|
|
2023
Q1 | $120M | Hold |
14,443,681
| – | – | 48.62% | 2 |
|
|
2022
Q4 | $133M | Hold |
14,443,681
| – | – | 42.4% | 2 |
|
|
2022
Q3 | $185M | Hold |
14,443,681
| – | – | 52.34% | 1 |
|
|
2022
Q2 | $191M | Hold |
14,443,681
| – | – | 79.84% | 1 |
|
|
2022
Q1 | $304M | Hold |
14,443,681
| – | – | 80.96% | 1 |
|
|
2021
Q4 | $347M | Buy |
+14,443,681
| New | +$347M | 76.67% | 1 |
|